BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 36611859)

  • 1. Targeting PCSK9 in Liver Cancer Cells Triggers Metabolic Exhaustion and Cell Death by Ferroptosis.
    Alannan M; Fatrouni H; Trézéguet V; Dittrich-Domergue F; Moreau P; Siegfried G; Liet B; Khatib AM; Grosset CF; Badran B; Fayyad-Kazan H; Merched AJ
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rewiring Lipid Metabolism by Targeting PCSK9 and HMGCR to Treat Liver Cancer.
    Alannan M; Trézéguet V; Amoêdo ND; Rossignol R; Mahfouf W; Rezvani HR; Dittrich-Domergue F; Moreau P; Lacomme S; Gontier E; Grosset CF; Badran B; Fayyad-Kazan H; Merched AJ
    Cancers (Basel); 2022 Dec; 15(1):. PubMed ID: 36612001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of p62-Keap1-Nrf2 Pathway Protects 6-Hydroxydopamine-Induced Ferroptosis in Dopaminergic Cells.
    Sun Y; He L; Wang T; Hua W; Qin H; Wang J; Wang L; Gu W; Li T; Li N; Liu X; Chen F; Tang L
    Mol Neurobiol; 2020 Nov; 57(11):4628-4641. PubMed ID: 32770451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tiliroside targets TBK1 to induce ferroptosis and sensitize hepatocellular carcinoma to sorafenib.
    Yang C; Lu T; Liu M; Yuan X; Li D; Zhang J; Zhou L; Xu M
    Phytomedicine; 2023 Mar; 111():154668. PubMed ID: 36657316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells.
    Sun X; Ou Z; Chen R; Niu X; Chen D; Kang R; Tang D
    Hepatology; 2016 Jan; 63(1):173-84. PubMed ID: 26403645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of Atg7-dependent autophagy by a novel inhibitor of the Keap1-Nrf2 protein-protein interaction from
    Sun Y; He L; Wang W; Xie Z; Zhang X; Wang P; Wang L; Yan C; Liu Z; Zhao J; Cui Z; Wang Y; Tang L; Zhang Z
    Food Funct; 2022 Jul; 13(14):7885-7900. PubMed ID: 35776077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A targetable CoQ-FSP1 axis drives ferroptosis- and radiation-resistance in KEAP1 inactive lung cancers.
    Koppula P; Lei G; Zhang Y; Yan Y; Mao C; Kondiparthi L; Shi J; Liu X; Horbath A; Das M; Li W; Poyurovsky MV; Olszewski K; Gan B
    Nat Commun; 2022 Apr; 13(1):2206. PubMed ID: 35459868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Camptothecin Sensitizes Hepatocellular Carcinoma Cells to Sorafenib- Induced Ferroptosis Via Suppression of Nrf2.
    Elkateb AS; Nofal S; Ali SA; Atya HB
    Inflammation; 2023 Aug; 46(4):1493-1511. PubMed ID: 37171695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophagy Inhibition Plays a Protective Role in Ferroptosis Induced by Alcohol via the p62-Keap1-Nrf2 Pathway.
    Zhao Y; Lu J; Mao A; Zhang R; Guan S
    J Agric Food Chem; 2021 Aug; 69(33):9671-9683. PubMed ID: 34388345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
    Shin D; Kim EH; Lee J; Roh JL
    Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dehydroabietic acid improves nonalcoholic fatty liver disease through activating the Keap1/Nrf2-ARE signaling pathway to reduce ferroptosis.
    Gao G; Xie Z; Li EW; Yuan Y; Fu Y; Wang P; Zhang X; Qiao Y; Xu J; Hölscher C; Wang H; Zhang Z
    J Nat Med; 2021 Jun; 75(3):540-552. PubMed ID: 33590347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
    Roh JL; Kim EH; Jang H; Shin D
    Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PCSK9 in Liver Cancers at the Crossroads between Lipid Metabolism and Immunity.
    Alannan M; Seidah NG; Merched AJ
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Nrf2 for ferroptosis-based therapy: Implications for overcoming ferroptosis evasion and therapy resistance in cancer.
    Lee J; Roh JL
    Biochim Biophys Acta Mol Basis Dis; 2023 Oct; 1869(7):166788. PubMed ID: 37302427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming the compensatory elevation of NRF2 renders hepatocellular carcinoma cells more vulnerable to disulfiram/copper-induced ferroptosis.
    Ren X; Li Y; Zhou Y; Hu W; Yang C; Jing Q; Zhou C; Wang X; Hu J; Wang L; Yang J; Wang H; Xu H; Li H; Tong X; Wang Y; Du J
    Redox Biol; 2021 Oct; 46():102122. PubMed ID: 34482117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitosan oligosaccharides enhance lipid droplets via down-regulation of PCSK9 gene expression in HepG2 cells.
    Yang X; Zhang J; Chen L; Wu Q; Yu C
    Exp Cell Res; 2018 May; 366(2):152-160. PubMed ID: 29548750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exosomes Derived from Baicalin-Pretreated Mesenchymal Stem Cells Alleviate Hepatocyte Ferroptosis after Acute Liver Injury via the Keap1-NRF2 Pathway.
    Zhao S; Huang M; Yan L; Zhang H; Shi C; Liu J; Zhao S; Liu H; Wang B
    Oxid Med Cell Longev; 2022; 2022():8287227. PubMed ID: 35910831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitochondrial TSPO Promotes Hepatocellular Carcinoma Progression through Ferroptosis Inhibition and Immune Evasion.
    Zhang D; Man D; Lu J; Jiang Y; Ding B; Su R; Tong R; Chen J; Yang B; Zheng S; Chen D; Wu J
    Adv Sci (Weinh); 2023 May; 10(15):e2206669. PubMed ID: 36994647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferroptosis in Liver Diseases: An Overview.
    Capelletti MM; Manceau H; Puy H; Peoc'h K
    Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664576
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1,25(OH)
    Cheng K; Huang Y; Wang C
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.